Tempus is a technology company that specializes in precision medicine, specifically aiming to harness and analyze clinical and molecular data at scale to empower healthcare providers to make more informed treatment decisions. By integrating genomic sequencing and bioinformatics, Tempus offers tools and insights that enhance the diagnosis and treatment of diseases, particularly cancer, and other conditions. The company's platform provides healthcare professionals with data-driven insights to tailor patient treatments effectively.